8-K current report · filed Aug 27, 2026

Avantor Inc (AVTR) 8-K Current Report: August 27, 2026

Item 5.02AVTR overview

Short answer

Avantor Inc (AVTR) filed an 8-K current report with the SEC on August 27, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Benoit Gourdier, Executive Vice President, Bioscience and Medtech Products, departs Avantor after October 14, 2026.

Avantor Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Benoit Gourdier, Executive Vice President, Bioscience and Medtech Products, departs Avantor after October 14, 2026
  • Transition period supports segment integration activities before leadership exit
  • Severance benefits contingent on employment and compliance through October 14, 2026
  • Benefits materially consistent with Avantor’s Executive Severance and Change in Control Plan

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Avantor Inc 8-K filings

Get the next AVTR 8-K as it lands

Follow AVTR for push alerts, or ask the research agent what this filing means.